ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) OverviewZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LSPRU.
Quarterly EBIT
-$1.30B
↑ 39.16% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$24.65B
↓ 457.98% YoY
Trailing 12 months ending Mar 31, 2026